Oxcarbazepine
Product Images NDC 54868-5830

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 54868-5830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Oxcarbazepine Structure (394a5bd6 976a 4220 8b02 31b0f222b129 01)

Chemical structure diagram of oxcarbazepine, showing the arrangement of its molecular components, including fused ring structures and functional groups with nitrogen and oxygen atoms.*

FDA Label Image

Figure 1 (394a5bd6 976a 4220 8b02 31b0f222b129 02)

A Kaplan-Meier plot showing exit rates over time in days from Day 2 at 8 am to Day 11 at 8 am for two treatment groups: Oxcarbazepine and placebo. The graph includes a log-rank test p-value of 0.0001, indicating statistical comparison between the groups' exit rates.*

FDA Label Image

Figure 2 (394a5bd6 976a 4220 8b02 31b0f222b129 03)

A line graph displaying seizure rate over time in days from first dose to first seizure. It compares two treatment groups: Oxcarbazepine and Placebo. The x-axis represents days, and the y-axis represents seizure rate. The graph includes a log-rank test result with a p-value of 0.046, indicating a statistical comparison between the groups.*

FDA Label Image

Figure 3 (394a5bd6 976a 4220 8b02 31b0f222b129 04)

A Kaplan-Meier survival curve chart comparing exit rates over time (days) between two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days, and the y-axis represents the exit rate, ranging from 0 to 1. The chart includes a log-rank test p-value of 0.0001 indicating statistical comparison between the groups.*

FDA Label Image

Figure 4 (394a5bd6 976a 4220 8b02 31b0f222b129 05)

A Kaplan-Meier survival curve chart depicting exit rates over time (days) for two treatment groups labeled HIGH and LOW. The y-axis shows the exit rate from 0.0 to 1.0, and the x-axis shows time to exit in days from 0 to 130. The HIGH group shows a steeper increase in exit rate than the LOW group. A log-rank test with p-value 0.0001 is indicated on the chart.*

FDA Label Image

Glenmark Logo (394a5bd6 976a 4220 8b02 31b0f222b129 06)

FDA Label Image

Glenmark Logo (394a5bd6 976a 4220 8b02 31b0f222b129 07)

FDA Label Image

Oxcarbazepine Tablets 150 mg Bottle Label (5830)

Oxcarbazepine 150 mg tablet bottle label from Physicians Total Care, Inc. The label includes the NDC number 54868-5830-1 and states the package contains 60 tablets. It displays standard cautionary text about prescription requirements and storage instructions, including keeping the medication out of reach of children and storing it at controlled room temperature. Batch and expiration date sections are also shown.*

FDA Label Image

Oxcarbazepine Tablets 300 mg Bottle Label (6073)

Oxcarbazepine 300 mg tablet blister pack label by Physicians Total Care, Inc. The label indicates 60 tablets per bottle and includes cautionary, storage, and dosage information. The label also shows the NDC number, expiration date, lot number, and barcode.*

FDA Label Image

Oxcarbazepine Tablets 600 mg Bottle Label (6129)

Oxcarbazepine 600 mg tablets bottle label from Physicians Total Care, Inc. The label indicates a quantity of 60 tablets. It includes standard warnings such as a federal law caution prohibiting dispensing without a prescription, usage instructions to take as directed by a healthcare professional, and storage information to keep the bottle tightly closed and store at controlled room temperature. The label also displays the lot number and expiration date sections, along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.